Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.26 – $0.26
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3M | $62.4M | $26.6M | $6.8M | $13.4M | $674.0K | $2.0M | $6.6M |
| Cost of revenue | $0 | $0 | $0 | $551.0K | $59.0K | $672.0K | $2.0M | $2.9M |
| Gross profit | $5.3M | $74.6M | $26.6M | $6.8M | $13.3M | $2.0K | $1.0K | $3.7M |
| Gross margin | 100.0% | 119.6% | 100.0% | 100.0% | 99.6% | 0.3% | 0.1% | 55.7% |
| R&D | $24.1M | $58.1M | $44.5M | $29.2M | $27.5M | $13.9M | $21.0M | $1.7M |
| Operating income | −$21.9M | $314.0K | −$24.7M | −$29.8M | −$22.5M | −$21.9M | −$28.8M | −$4.3M |
| EBITDA | −$21.9M | $1.5M | −$25.3M | −$29.7M | −$20.7M | −$27.0M | −$12.2M | −$4.2M |
| Net income | −$22.3M | $1.3M | −$25.7M | −$31.9M | −$23.8M | −$31.4M | −$35.1M | −$18.3M |
| Net margin | -421.5% | 2.1% | -96.9% | -468.1% | -177.4% | -4658.5% | -1771.3% | -275.8% |
| EPS (diluted) | -0.97 | 0.05 | -0.99 | -1.16 | -0.83 | -1.08 | -0.91 | -0.42 |
Annual figures · source: Financial Modeling Prep
POXEL SA
No one on the platform currently holds PXXLF.
No tracked institution reports a position in PXXLF as of their last filing.
No one on the platform has traded PXXLF yet.
| $13M |
| — |
| LVCLYLiving Cell Technologies Limited | $0.03 | +24.39% | $11M | — |
| NOXOFNoxopharm Limited | $0.04 | +0.00% | $15M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.